Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Gritstone bio Inc.’s current trading price is -71.62% away from its 52-week high, while its distance from the 52-week low is -2.35%. The stock’s price range during this period has varied between $1.70 and $5.85. The company, active in the Healthcare sector, saw a trading volume of around 1.0 million for the day, considerably higher average daily volume of 0.6 million observed over the last three months.
Gritstone bio Inc. (GRTS) has a current stock price of $1.66. During the previous trading session, the stock witnessed a notable rise, reaching a high of $1.80 after opening at $1.79. The stock’s low for the day was $1.65, and it eventually closed at $1.76.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Gritstone bio Inc.’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $5.85 on 08/16/22, and the lowest price during the same period was recorded at $1.70 on 05/25/23.
How Financial Performance Impacts Market Capitalization
Gritstone bio Inc. (GRTS) has experienced a quarterly decline of -31.40% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 144.57M and boasts a workforce of 233 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.6981, with a change in price of -1.7900. Similarly, Gritstone bio Inc. recorded 691,222 in trading volume during the last 100 days, posting a change of -51.88%.
How GRTS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for GRTS stands at 0.21. Similarly, the long-term debt-to-equity ratio is also 0.21.
GRTS Stock Stochastic Average
As of today, the raw stochastic average of Gritstone bio Inc. over the past 50 days is 0.63%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 0.95%. Additionally, the Stochastic %K and %D values for the company were 3.43% and 7.83%, respectively, over the past 20 days.
GRTS Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -51.88% this year. Over the last six months, there has been a stronger performance of -47.80%. The price of GRTS leaped by -30.25% during the last 30 days period. For the last 5-days stocks have slided -13.54%.